Stryker Corporation (SYK): insider & executive buying
Stryker Corporation · Health Care · ref. ETF XLV · price $282.55
In short — 1 insider bought Stryker Corporation over ~6 months (1 buy, total $27k, latest Jun 26, 19). Public Form 4 data, informative (not a performance signal).
Are Stryker Corporation's executives buying their own shares? Here are the disclosed insider buys over the last 6 months — a transparency data point, not an outperformance signal.
📈 1-year price
$282.55-23.6% over range
Oct 14, 25low $269.75 · high $388.35Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
82% recommend buying · 17 analysts
Latest insider buys on Stryker Corporation
| Date | Insider | Role | Shares | Amount |
|---|---|---|---|---|
| Jun 26, 19 | Brainerd Mary K | Dir | 131 | $27k |
⚠️ Open-market buys reported to the SEC (Form 4). Transparency data, not advice nor an outperformance signal (our backtests show no reliable edge).
Frequently asked questions
Have Stryker Corporation's executives bought shares recently?
1 Stryker Corporation insider(s) bought $27k over ~6 months (latest Jun 26, 19). A buy shows confidence, but our backtests show no performance edge.
Is insider buying a good signal for SYK?
It's useful transparency data, but NOT a performance guarantee: our historical tests show no reliable edge from following insider buys. Cross-check with fundamentals and analyst views.
Where does this data come from?
From Form 4 filings with the SEC (mandatory for officers and 10%+ holders), aggregated and refreshed regularly.
💬 A question about Stryker Corporation? The JPI assistant answers using our backtest data.